Search Mailing List Archives


Limit search to: Subject & Body Subject Author
Sort by: Reverse Sort
Limit to: All This Week Last Week This Month Last Month
Select Date Range     through    

[bioontology-support] 8th Cell Based Assay & Screening Technologies Conference

Cell Based Assay & Screening Technologies cbas at lifescienceshome.com
Wed Sep 4 15:53:53 PDT 2013


If you can't view this page, please visit: http://www.gtcbio.com/newsletter/assay13I-w.htm JMEL-25246 
  
8th Cell Based Assay & Screening Technologies Conference
Early Registration Discount Deadline Approaching
Sign up by September 6, 2013 and receive 20% off the registration price.
Register 3 people for the price of 2 with the discount code rcdvb.

Join your colleagues from industry and academia to hear relevant scientific presentations, engage in lively discussions, and network at the 8th Cell Based Assay & Screening Technologies Conference at the Sheraton Fisherman's Wharf in San Francisco, CA on November 6-8, 2013. Leading researchers in the field of 3D cell culture assays as well as stem cell-based screening technologies will gather to discuss topics such as advances in phenotypic screening, the latest in flow cytometry, and the use of stem cells and iPS cells for drug discovery, and many more.

Five presentations we don't want you to miss:
  
Keynote Presentation: Stem Cell-Based Screening and Expanding Drug Target Space for Heart Failure
Mark Mercola, Professor and Director of the Muscle Development and Regeneration Program, Sanford-Burnham Medical Research Institute; Professor, University of California, San Diego
Using a combination of primary target-based screening coupled to secondary functional kinetic imaging cytometry screening, new microRNA targets were identified that repress contractile function in the heart and a specific RNA molecule was developed that can be delivered intravenously to halt established heart failure in a mouse pressure overload model.
  
Featured Presentation: The Third Dimension for High Throughput RNAi-Driven Target Identification
Geoffrey Bartholomeusz, Assistant Professor and Director of the siRNA Screening Service, University of Texas MD Anderson Cancer Center
Dr. Bartholomeusz will share how his lab as developed a 3D spheroid cell culture model to address their hypothesis that silencing targets that regulate tumor architecture will alter the integrity of the tumre, reduce the hypoxic state and sensitize the tumor to radiation and/or chemotherapy.
  
A Human Breathing Lung-on-a-Chip for Drug Screening and Nanotoxicology Applications
Dan Dongeun Huh, Wilf Family Term Chair and Assistant Professor, Bioengineering, University of Pennsylvania
This talk is about a biomimetic microsystem that reconstitutes the critical functional alveolar-capillary interface of the human lung for in vitro analysis of various physiological functions and disease processes, in addition to providing low-cost alternatives to animal and clinical studies for drug screening and toxicology applications.
  
Human Induced Pluripotent Stem Cells and Patient Specific Cell Based Disease Models for Drug Discovery
Anne Bang, Director of Cell-Based Disease Modeling and Screening, Sanford-Burnham Medical Research Institute
High content screening results of patient cells and development of iPSC based models for testing of drugs on disease relevant cell types will be discussed.
  
High Content Screen of an Arrayed cDNA Library in the Mesenchymal Stem Cell Model Line C3H/10T1/2
Patrick Collins, Scientist, Amgen
Dr. Collins will discuss a variety of multiparametric analyses used to reveal a variety of cDNA-induced phenotypes providing broader insight into mesenchymal stem cell biology. 
 

Session topics include:
    3D Cell Cultures & Physiologically Relevant Model Systems
    High Content & Image-Based Screening
    Innovations in Phenotypic Screening
    Advances in Functional Genomics & Screening 
    Stem Cells & iPS Cells 
    Panel Discussion: Venture Capitalist Perspective: Considerations in Life Sciences Funding
    Panel Discussion: Can In Vitro Physiological Model Systems Reduce Drug Attrition Rates in the Clinic?

 
8th Cell Based Assay & Screening Technologies Conference
November 6-8, 2013
Sheraton Fisherman's Wharf
San Francisco, CA
Agenda | Speakers | Venue | Register by September 6, 2013 and save up to $350 
CALL FOR PAPERS 
To be considered for an oral presentation, please submit an abstract by October 6, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.  
For business development & exhibiting opportunities, contact Amber Kempf, 626-256-6405 x110 or spex at gtcbio.com 
 

--------------------------------------------------------------------------------
 

Go to www.gtcbio.com to view GTC's upcoming conferences
  
This advertisement is sent to support at bioontology.org from GTC, 635 W. Foothill Blvd, Monrovia, CA 91016. If you prefer not to receive further messages from this sender, please forward this email to remove at gtcbio.com or use the following link to unsubscribe http://gtcbio.com/unsubscribe.php?emailid=support@bioontology.org 


-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mailman.stanford.edu/pipermail/bioontology-support/attachments/20130904/e161faf4/attachment.html>


More information about the bioontology-support mailing list